EASY BIO,Inc. (KOSDAQ:353810)
South Korea · Delayed Price · Currency is KRW 6,320.00
+30.00 (0.48%)
Sep 4, 2026, 3:30 PM KST
EASY BIO,Inc. Revenue
EASY BIO,Inc. had revenue of 148.13B KRW in the quarter ending June 30, 2026, with 30.18% growth. This brings the company's revenue in the last twelve months to 525.04B, up 15.45% year-over-year. In the year 2025, EASY BIO,Inc. had annual revenue of 476.94B with 24.10% growth.
Revenue (ttm)
525.04B
Revenue Growth
+15.45%
P/S Ratio
0.40
Revenue / Employee
814.01M
Employees
645
Market Cap
209.08B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 476.94B | 92.61B | 24.10% |
| Dec 31, 2024 | 384.33B | 218.95B | 132.39% |
| Dec 31, 2023 | 165.39B | 9.83B | 6.32% |
| Dec 31, 2022 | 155.56B | 26.10B | 20.16% |
| Dec 31, 2021 | 129.46B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Samsung C&T | 43.44T |
| Hanwha Aerospace | 29.95T |
| LG Energy Solution | 25.22T |
| Doosan Enerbility | 17.73T |
| GS Global | 4.25T |
| HL D&I Halla | 1.84T |
| Daedong | 1.53T |
| Dong-Ah Geological Engineering Company | 494.10B |